{"transactions":[{"id":850388,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":61700,"kind":"person","name":"Wyrick Susan D.","position":1,"cik":"0001568605","reported_name":"Wyrick Susan D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2026-03-10T16:15:55.000Z","date":"2026-03-07","kind":"exercise","planned":false,"acquired":false,"shares":3250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Sana Biotechnology, Inc. (\"Sana\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The award vested as to 25% of the restricted stock units on each of March 7, 2025 and 2026, and the remaining restricted stock units will vest in two equal installments on each of March 7, 2027 and 2028, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through each such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The award vested as to 25% of the restricted stock units on each of March 7, 2025 and 2026, and the remaining restricted stock units will vest in two equal installments on each of March 7, 2027 and 2028, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through each such date."}],"balance_after":6500,"derivative":{"underlying":"Common Stock","underlying_shares":3250},"source":{"system":"sec-edgar","filing":"0001568605-26-000008","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1568605/000156860526000008/primarydocument.xml","form_type":"4"}},{"id":850387,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":61700,"kind":"person","name":"Wyrick Susan D.","position":1,"cik":"0001568605","reported_name":"Wyrick Susan D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2026-03-10T16:15:55.000Z","date":"2026-03-06","kind":"exercise","planned":false,"acquired":false,"shares":10416,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Sana Biotechnology, Inc. (\"Sana\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The award vested as to 25% of the restricted stock units on March 6, 2026, and the remaining restricted stock units will vest in three equal installments on each of March 6, 2027, 2028 and 2029, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through each such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The award vested as to 25% of the restricted stock units on March 6, 2026, and the remaining restricted stock units will vest in three equal installments on each of March 6, 2027, 2028 and 2029, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through each such date."}],"balance_after":31251,"derivative":{"underlying":"Common Stock","underlying_shares":10416},"source":{"system":"sec-edgar","filing":"0001568605-26-000008","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1568605/000156860526000008/primarydocument.xml","form_type":"4"}},{"id":850386,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":61700,"kind":"person","name":"Wyrick Susan D.","position":1,"cik":"0001568605","reported_name":"Wyrick Susan D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-03-10T16:15:55.000Z","date":"2026-03-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":1045,"price":3.1,"value":3239.5,"ownership":{"direct":true},"balance_after":196196,"source":{"system":"sec-edgar","filing":"0001568605-26-000008","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1568605/000156860526000008/primarydocument.xml","form_type":"4"}},{"id":850385,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":61700,"kind":"person","name":"Wyrick Susan D.","position":1,"cik":"0001568605","reported_name":"Wyrick Susan D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-03-10T16:15:55.000Z","date":"2026-03-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":3342,"price":3.13,"value":10460.46,"ownership":{"direct":true},"balance_after":197241,"source":{"system":"sec-edgar","filing":"0001568605-26-000008","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1568605/000156860526000008/primarydocument.xml","form_type":"4"}},{"id":850384,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":61700,"kind":"person","name":"Wyrick Susan D.","position":1,"cik":"0001568605","reported_name":"Wyrick Susan D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-03-10T16:15:55.000Z","date":"2026-03-07","kind":"exercise","planned":false,"acquired":true,"shares":3250,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":200583,"source":{"system":"sec-edgar","filing":"0001568605-26-000008","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1568605/000156860526000008/primarydocument.xml","form_type":"4"}},{"id":850383,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":61700,"kind":"person","name":"Wyrick Susan D.","position":1,"cik":"0001568605","reported_name":"Wyrick Susan D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-03-10T16:15:55.000Z","date":"2026-03-06","kind":"exercise","planned":false,"acquired":true,"shares":10416,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":197333,"source":{"system":"sec-edgar","filing":"0001568605-26-000008","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1568605/000156860526000008/primarydocument.xml","form_type":"4"}},{"id":855494,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":61700,"kind":"person","name":"Wyrick Susan D.","position":1,"cik":"0001568605","reported_name":"Wyrick Susan D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-06T16:53:37.000Z","date":"2026-03-05","kind":"grant","planned":false,"acquired":true,"shares":206250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests and becomes exercisable as to 25% of the underlying shares on March 5, 2027 and in 36 equal monthly installments thereafter, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through each such date."}],"balance_after":206250,"derivative":{"exercise_price":3.41,"expiration_date":"2036-03-04","underlying":"Common Stock","underlying_shares":206250},"source":{"system":"sec-edgar","filing":"0001568605-26-000006","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1568605/000156860526000006/primarydocument.xml","form_type":"4"}},{"id":855493,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":61700,"kind":"person","name":"Wyrick Susan D.","position":1,"cik":"0001568605","reported_name":"Wyrick Susan D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2026-03-06T16:53:37.000Z","date":"2026-03-05","kind":"grant","planned":false,"acquired":true,"shares":45833,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Sana Biotechnology, Inc. (\"Sana\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in four equal installments on each of March 5, 2027, 2028, 2029 and 2030, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through each such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in four equal installments on each of March 5, 2027, 2028, 2029 and 2030, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through each such date."}],"balance_after":45833,"derivative":{"underlying":"Common Stock","underlying_shares":45833},"source":{"system":"sec-edgar","filing":"0001568605-26-000006","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1568605/000156860526000006/primarydocument.xml","form_type":"4"}},{"id":860746,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":61700,"kind":"person","name":"Wyrick Susan D.","position":1,"cik":"0001568605","reported_name":"Wyrick Susan D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2026-03-04T16:17:38.000Z","date":"2026-03-02","kind":"exercise","planned":false,"acquired":false,"shares":1525,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Sana Biotechnology, Inc. (\"Sana\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The award vested as to 25% of the restricted stock units on each of March 2, 2024, 2025 and 2026, and the remaining restricted stock units will vest on March 2, 2027, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The award vested as to 25% of the restricted stock units on each of March 2, 2024, 2025 and 2026, and the remaining restricted stock units will vest on March 2, 2027, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through such date."}],"balance_after":1525,"derivative":{"underlying":"Common Stock","underlying_shares":1525},"source":{"system":"sec-edgar","filing":"0001568605-26-000004","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1568605/000156860526000004/primarydocument.xml","form_type":"4"}},{"id":860745,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":61700,"kind":"person","name":"Wyrick Susan D.","position":1,"cik":"0001568605","reported_name":"Wyrick Susan D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-03-04T16:17:38.000Z","date":"2026-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":491,"price":3.91,"value":1919.81,"ownership":{"direct":true},"balance_after":186917,"source":{"system":"sec-edgar","filing":"0001568605-26-000004","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1568605/000156860526000004/primarydocument.xml","form_type":"4"}},{"id":860744,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":61700,"kind":"person","name":"Wyrick Susan D.","position":1,"cik":"0001568605","reported_name":"Wyrick Susan D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-03-04T16:17:38.000Z","date":"2026-03-02","kind":"exercise","planned":false,"acquired":true,"shares":1525,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":187408,"source":{"system":"sec-edgar","filing":"0001568605-26-000004","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1568605/000156860526000004/primarydocument.xml","form_type":"4"}},{"id":945742,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":61700,"kind":"person","name":"Wyrick Susan D.","position":1,"cik":"0001568605","reported_name":"Wyrick Susan D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2026-01-06T16:18:40.000Z","date":"2026-01-02","kind":"exercise","planned":false,"acquired":false,"shares":7500,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Sana Biotechnology, Inc. common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Sana Biotechnology, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The award vested as to 40% of the restricted stock units on January 2, 2025 and 60% of the restricted stock units on January 2, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The award vested as to 40% of the restricted stock units on January 2, 2025 and 60% of the restricted stock units on January 2, 2026."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001568605-26-000002","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1568605/000156860526000002/primarydocument.xml","form_type":"4"}},{"id":945741,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":61700,"kind":"person","name":"Wyrick Susan D.","position":1,"cik":"0001568605","reported_name":"Wyrick Susan D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-01-06T16:18:40.000Z","date":"2026-01-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":2407,"price":4.27,"value":10277.89,"ownership":{"direct":true},"balance_after":185883,"source":{"system":"sec-edgar","filing":"0001568605-26-000002","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1568605/000156860526000002/primarydocument.xml","form_type":"4"}},{"id":945740,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":61700,"kind":"person","name":"Wyrick Susan D.","position":1,"cik":"0001568605","reported_name":"Wyrick Susan D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-01-06T16:18:40.000Z","date":"2026-01-02","kind":"exercise","planned":false,"acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":188290,"source":{"system":"sec-edgar","filing":"0001568605-26-000002","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1568605/000156860526000002/primarydocument.xml","form_type":"4"}},{"id":967095,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":61700,"kind":"person","name":"Wyrick Susan D.","position":1,"cik":"0001568605","reported_name":"Wyrick Susan D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2025-12-16T16:16:41.000Z","date":"2025-12-13","kind":"exercise","planned":false,"acquired":false,"shares":3400,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Sana Biotechnology, Inc. common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Sana Biotechnology, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The award vested as to 100% of the restricted stock units on December 13, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The award vested as to 100% of the restricted stock units on December 13, 2025."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3400},"source":{"system":"sec-edgar","filing":"0001568605-25-000007","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1568605/000156860525000007/primarydocument.xml","form_type":"4"}},{"id":967094,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":61700,"kind":"person","name":"Wyrick Susan D.","position":1,"cik":"0001568605","reported_name":"Wyrick Susan D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-12-16T16:16:41.000Z","date":"2025-12-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":873,"price":5.22,"value":4557.06,"ownership":{"direct":true},"balance_after":180790,"source":{"system":"sec-edgar","filing":"0001568605-25-000007","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1568605/000156860525000007/primarydocument.xml","form_type":"4"}},{"id":967093,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":61700,"kind":"person","name":"Wyrick Susan D.","position":1,"cik":"0001568605","reported_name":"Wyrick Susan D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-12-16T16:16:41.000Z","date":"2025-12-13","kind":"exercise","planned":false,"acquired":true,"shares":3400,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":181663,"source":{"system":"sec-edgar","filing":"0001568605-25-000007","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1568605/000156860525000007/primarydocument.xml","form_type":"4"}},{"id":978755,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":61700,"kind":"person","name":"Wyrick Susan D.","position":1,"cik":"0001568605","reported_name":"Wyrick Susan D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2025-12-05T17:04:09.000Z","date":"2025-12-03","kind":"exercise","planned":false,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of Sana common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The restricted stock units vested in two equal installments on each of June 3, 2025 and December 3, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The restricted stock units vested in two equal installments on each of June 3, 2025 and December 3, 2025."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001568605-25-000005","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1568605/000156860525000005/primarydocument.xml","form_type":"4"}},{"id":978754,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":61700,"kind":"person","name":"Wyrick Susan D.","position":1,"cik":"0001568605","reported_name":"Wyrick Susan D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2025-12-05T17:04:09.000Z","date":"2025-06-03","kind":"exercise","planned":false,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of Sana common stock."},{"field":"date","element":"transactionDate","label":"F1","text":"This transaction is being reported late due to an inadvertent administrative error and not any error of the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The restricted stock units vested in two equal installments on each of June 3, 2025 and December 3, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The restricted stock units vested in two equal installments on each of June 3, 2025 and December 3, 2025."}],"balance_after":10000,"derivative":{"underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001568605-25-000005","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1568605/000156860525000005/primarydocument.xml","form_type":"4"}},{"id":978753,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":61700,"kind":"person","name":"Wyrick Susan D.","position":1,"cik":"0001568605","reported_name":"Wyrick Susan D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-12-05T17:04:09.000Z","date":"2024-12-13","kind":"grant","planned":false,"acquired":true,"shares":5100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This transaction is being reported late due to an inadvertent administrative error and not any error of the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option vests as to 100% of the shares underlying the option on January 13, 2026, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through such date."}],"balance_after":5100,"derivative":{"exercise_price":1.89,"expiration_date":"2034-12-12","underlying":"Common Stock","underlying_shares":5100},"source":{"system":"sec-edgar","filing":"0001568605-25-000005","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1568605/000156860525000005/primarydocument.xml","form_type":"4"}},{"id":978752,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":61700,"kind":"person","name":"Wyrick Susan D.","position":1,"cik":"0001568605","reported_name":"Wyrick Susan D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2025-12-05T17:04:09.000Z","date":"2024-12-13","kind":"grant","planned":false,"acquired":true,"shares":3400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of Sana common stock."},{"field":"date","element":"transactionDate","label":"F1","text":"This transaction is being reported late due to an inadvertent administrative error and not any error of the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The award vests as to 100% of the restricted stock units on December 13, 2025, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The award vests as to 100% of the restricted stock units on December 13, 2025, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through such date."}],"balance_after":3400,"derivative":{"underlying":"Common Stock","underlying_shares":3400},"source":{"system":"sec-edgar","filing":"0001568605-25-000005","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1568605/000156860525000005/primarydocument.xml","form_type":"4"}},{"id":978751,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":61700,"kind":"person","name":"Wyrick Susan D.","position":1,"cik":"0001568605","reported_name":"Wyrick Susan D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-12-05T17:04:09.000Z","date":"2025-12-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":2565,"price":4.44,"value":11388.6,"ownership":{"direct":true},"balance_after":178263,"source":{"system":"sec-edgar","filing":"0001568605-25-000005","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1568605/000156860525000005/primarydocument.xml","form_type":"4"}},{"id":978750,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":61700,"kind":"person","name":"Wyrick Susan D.","position":1,"cik":"0001568605","reported_name":"Wyrick Susan D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-12-05T17:04:09.000Z","date":"2025-12-03","kind":"exercise","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 3,000 shares acquired on November 14, 2025 pursuant to the ESPP."}],"balance_after":180828,"source":{"system":"sec-edgar","filing":"0001568605-25-000005","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1568605/000156860525000005/primarydocument.xml","form_type":"4"}},{"id":978749,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":61700,"kind":"person","name":"Wyrick Susan D.","position":1,"cik":"0001568605","reported_name":"Wyrick Susan D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-12-05T17:04:09.000Z","date":"2025-06-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":2567,"price":2.32,"value":5955.44,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This transaction is being reported late due to an inadvertent administrative error and not any error of the reporting person."}],"balance_after":167828,"source":{"system":"sec-edgar","filing":"0001568605-25-000005","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1568605/000156860525000005/primarydocument.xml","form_type":"4"}},{"id":978748,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":61700,"kind":"person","name":"Wyrick Susan D.","position":1,"cik":"0001568605","reported_name":"Wyrick Susan D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-12-05T17:04:09.000Z","date":"2025-06-03","kind":"exercise","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This transaction is being reported late due to an inadvertent administrative error and not any error of the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 3,000 shares acquired on May 15, 2025 pursuant to Sana Biotechnology, Inc.'s (\"Sana\") 2021 Employee Stock Purchase Plan (the \"ESPP\")."}],"balance_after":170395,"source":{"system":"sec-edgar","filing":"0001568605-25-000005","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1568605/000156860525000005/primarydocument.xml","form_type":"4"}},{"id":1214519,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":61700,"kind":"person","name":"Wyrick Susan D.","position":1,"cik":"0001568605","reported_name":"Wyrick Susan D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2025-03-10T20:13:08.000Z","date":"2025-03-07","kind":"exercise","planned":false,"acquired":false,"shares":3250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Sana Biotechnology, Inc. (\"Sana\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The award vested as to 25% of the restricted stock units on March 7, 2025 and the remaining restricted stock units will vest in three equal installments on each of March 7, 2026, 2027 and 2028, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through each such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The award vested as to 25% of the restricted stock units on March 7, 2025 and the remaining restricted stock units will vest in three equal installments on each of March 7, 2026, 2027 and 2028, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through each such date."}],"balance_after":9750,"derivative":{"underlying":"Common Stock","underlying_shares":3250},"source":{"system":"sec-edgar","filing":"0001562180-25-002274","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1568605/000156218025002274/primarydocument.xml","form_type":"4"}},{"id":1214518,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":61700,"kind":"person","name":"Wyrick Susan D.","position":1,"cik":"0001568605","reported_name":"Wyrick Susan D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-10T20:13:08.000Z","date":"2025-03-06","kind":"grant","planned":false,"acquired":true,"shares":187500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests and becomes exercisable as to 25% of the underlying shares on March 6, 2026 and in 36 equal monthly installments thereafter, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through each such date."}],"balance_after":187500,"derivative":{"exercise_price":2.55,"expiration_date":"2035-03-05","underlying":"Common Stock","underlying_shares":187500},"source":{"system":"sec-edgar","filing":"0001562180-25-002274","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1568605/000156218025002274/primarydocument.xml","form_type":"4"}},{"id":1214517,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":61700,"kind":"person","name":"Wyrick Susan D.","position":1,"cik":"0001568605","reported_name":"Wyrick Susan D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2025-03-10T20:13:08.000Z","date":"2025-03-06","kind":"grant","planned":false,"acquired":true,"shares":41667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Sana Biotechnology, Inc. (\"Sana\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in four equal installments on each of March 6, 2026, 2027, 2028 and 2029, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through each such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in four equal installments on each of March 6, 2026, 2027, 2028 and 2029, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through each such date."}],"balance_after":41667,"derivative":{"underlying":"Common Stock","underlying_shares":41667},"source":{"system":"sec-edgar","filing":"0001562180-25-002274","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1568605/000156218025002274/primarydocument.xml","form_type":"4"}},{"id":1214516,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":61700,"kind":"person","name":"Wyrick Susan D.","position":1,"cik":"0001568605","reported_name":"Wyrick Susan D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-03-10T20:13:08.000Z","date":"2025-03-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":836,"price":2.56,"value":2140.16,"ownership":{"direct":true},"balance_after":157395,"source":{"system":"sec-edgar","filing":"0001562180-25-002274","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1568605/000156218025002274/primarydocument.xml","form_type":"4"}},{"id":1214515,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":61700,"kind":"person","name":"Wyrick Susan D.","position":1,"cik":"0001568605","reported_name":"Wyrick Susan D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-03-10T20:13:08.000Z","date":"2025-03-07","kind":"exercise","planned":false,"acquired":true,"shares":3250,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":158231,"source":{"system":"sec-edgar","filing":"0001562180-25-002274","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1568605/000156218025002274/primarydocument.xml","form_type":"4"}},{"id":1235222,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":61700,"kind":"person","name":"Wyrick Susan D.","position":1,"cik":"0001568605","reported_name":"Wyrick Susan D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2025-03-03T19:28:58.000Z","date":"2025-03-02","kind":"exercise","planned":false,"acquired":false,"shares":1525,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Sana Biotechnology, Inc. (\"Sana\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The award vested as to 25% of the restricted stock units on each of March 2, 2024 and 2025, and the remaining restricted stock units vest in two equal installments on each of March 2, 2026 and 2027, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through each such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The award vested as to 25% of the restricted stock units on each of March 2, 2024 and 2025, and the remaining restricted stock units vest in two equal installments on each of March 2, 2026 and 2027, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through each such date."}],"balance_after":3050,"derivative":{"underlying":"Common Stock","underlying_shares":1525},"source":{"system":"sec-edgar","filing":"0001562180-25-001888","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1568605/000156218025001888/primarydocument.xml","form_type":"4"}},{"id":1235221,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":61700,"kind":"person","name":"Wyrick Susan D.","position":1,"cik":"0001568605","reported_name":"Wyrick Susan D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-03-03T19:28:58.000Z","date":"2025-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":490,"price":2.56,"value":1254.4,"ownership":{"direct":true},"balance_after":154981,"source":{"system":"sec-edgar","filing":"0001562180-25-001888","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1568605/000156218025001888/primarydocument.xml","form_type":"4"}},{"id":1235220,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":61700,"kind":"person","name":"Wyrick Susan D.","position":1,"cik":"0001568605","reported_name":"Wyrick Susan D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-03-03T19:28:58.000Z","date":"2025-03-02","kind":"exercise","planned":false,"acquired":true,"shares":1525,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":155471,"source":{"system":"sec-edgar","filing":"0001562180-25-001888","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1568605/000156218025001888/primarydocument.xml","form_type":"4"}},{"id":1313608,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":61700,"kind":"person","name":"Wyrick Susan D.","position":1,"cik":"0001568605","reported_name":"Wyrick Susan D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2025-01-03T16:15:57.000Z","date":"2025-01-02","kind":"exercise","planned":false,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Sana common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The award vested as to 40% of the restricted stock units on January 2, 2025 and the remaining 60% of the restricted stock units will vest on January 2, 2026, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The award vested as to 40% of the restricted stock units on January 2, 2025 and the remaining 60% of the restricted stock units will vest on January 2, 2026, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through such date."}],"balance_after":7500,"derivative":{"underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001562180-25-000105","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1568605/000156218025000105/primarydocument.xml","form_type":"4"}},{"id":1313607,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":61700,"kind":"person","name":"Wyrick Susan D.","position":1,"cik":"0001568605","reported_name":"Wyrick Susan D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-01-03T16:15:57.000Z","date":"2025-01-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":1566,"price":1.65,"value":2583.9,"ownership":{"direct":true},"balance_after":153946,"source":{"system":"sec-edgar","filing":"0001562180-25-000105","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1568605/000156218025000105/primarydocument.xml","form_type":"4"}},{"id":1313606,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":61700,"kind":"person","name":"Wyrick Susan D.","position":1,"cik":"0001568605","reported_name":"Wyrick Susan D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-01-03T16:15:57.000Z","date":"2025-01-02","kind":"exercise","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 3,000 shares acquired on November 15, 2024 pursuant to Sana Biotechnology, Inc.'s (\"Sana\") 2021 Employee Stock Purchase Plan."}],"balance_after":155512,"source":{"system":"sec-edgar","filing":"0001562180-25-000105","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1568605/000156218025000105/primarydocument.xml","form_type":"4"}}]}